Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells
- 28 May 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 66 (1) , 115-124
- https://doi.org/10.1016/s0006-2952(03)00254-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- NF-κB as a therapeutic target in cancerTrends in Molecular Medicine, 2002
- The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational changeOncogene, 2001
- Advances in the treatment of non-small cell lung cancer: Molecular markers take the stageSeminars in Oncology, 2001
- Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial LevelThe Journal of cell biology, 2000
- Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancerLung Cancer, 1999
- THE ROLE OF CASPASE 3 AND BclxLIN THE ACTION OF INTERLEUKIN 7 (IL-7): A SURVIVAL FACTOR IN ACTIVATED HUMAN T CELLSCytokine, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- Importance of the Bcl-2 family in cell death regulationCellular and Molecular Life Sciences, 1996
- Molecular cloning of human p38 MAP kinaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992